MA52883A - Composition pharmaceutique pour dermatologie et ses utilisations - Google Patents

Composition pharmaceutique pour dermatologie et ses utilisations

Info

Publication number
MA52883A
MA52883A MA052883A MA52883A MA52883A MA 52883 A MA52883 A MA 52883A MA 052883 A MA052883 A MA 052883A MA 52883 A MA52883 A MA 52883A MA 52883 A MA52883 A MA 52883A
Authority
MA
Morocco
Prior art keywords
dermatology
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
MA052883A
Other languages
English (en)
Inventor
Prieto Manuel Hermida
Pardo Luis Mariñas
Original Assignee
Prieto Manuel Hermida
Marinas Pardo Luis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prieto Manuel Hermida, Marinas Pardo Luis filed Critical Prieto Manuel Hermida
Publication of MA52883A publication Critical patent/MA52883A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
MA052883A 2018-06-15 2019-06-14 Composition pharmaceutique pour dermatologie et ses utilisations MA52883A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18382430 2018-06-15

Publications (1)

Publication Number Publication Date
MA52883A true MA52883A (fr) 2021-05-26

Family

ID=62791699

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052883A MA52883A (fr) 2018-06-15 2019-06-14 Composition pharmaceutique pour dermatologie et ses utilisations

Country Status (9)

Country Link
US (2) US11413314B2 (fr)
EP (2) EP3806872A1 (fr)
JP (1) JP2021528489A (fr)
KR (1) KR20210021358A (fr)
CN (1) CN112584846A (fr)
AU (1) AU2019287353A1 (fr)
CA (1) CA3103043A1 (fr)
MA (1) MA52883A (fr)
WO (1) WO2019238952A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL434622A1 (pl) * 2020-07-10 2022-01-17 Bioceltix Spółka Akcyjna Sposób enkapsulacji białkowej substancji czynnej wykorzystujący techniki elektroosadzania, immunomodulująca kompozycja zawierająca białkową substancję czynną oraz polimer oraz jej zastosowanie do wytwarzania kompozycji weterynaryjnej do leczenia atopowego zapalenia skóry u zwierząt
PL434621A1 (pl) * 2020-07-10 2022-01-17 Bioceltix Spółka Akcyjna Sposób enkapsulacji białkowej substancji czynnej wykorzystujący techniki elektroosadzania, immunomodulująca kompozycja zawierająca białkową substancję czynną oraz polimer oraz jej zastosowanie do wytwarzania kompozycji farmaceutycznej do leczenia atopowego zapalenia skóry u ludzi
JP7497094B1 (ja) 2023-09-07 2024-06-10 株式会社 バイオミメティクスシンパシーズ 腸内細菌叢改善のための組成物及びその応用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729377B2 (en) 1997-10-23 2001-02-01 Asterias Biotherapeutics, Inc. Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6139524A (en) 1998-10-16 2000-10-31 Scimed Life Systems, Inc. Stent delivery system with perfusion
US7122019B1 (en) 2000-11-28 2006-10-17 Flowmedica Inc. Intra-aortic renal drug delivery catheter
EP3184630B1 (fr) 2005-09-23 2019-07-17 TiGenix, S.A.U. Populations cellulaires ayant une activité immuno-régulatrice, procédé d'isolement et utilisations
EP2617428A1 (fr) * 2006-08-15 2013-07-24 Agency for Science, Technology and Research Milieu conditionné d'une cellule souche mésenchymateuse
CA2629652A1 (fr) 2007-04-24 2008-10-24 Yaojiong Wu Compositions permettant la prevention ou le traitement des defauts de la peau et methodes d'utilisation connexes
WO2012030968A1 (fr) * 2010-08-31 2012-03-08 Renovocyte, LLC Thérapies systémiques par cellules souches allogéniques pour le traitement de maladies chez des animaux
DK2744892T3 (en) * 2011-09-23 2019-04-23 Cell Ideas Pty Ltd THERAPEUTICS USING FAT CELLS AND CELL SECRETIONS
KR102246369B1 (ko) * 2011-11-30 2021-04-29 아스텔라스 인스티튜트 포 리제너러티브 메디슨 중간엽 간질 세포 및 이에 관련된 용도
IN2013MU02046A (fr) * 2013-06-17 2015-06-05 Kasiak Res Pvt Ltd
KR101646236B1 (ko) * 2014-03-07 2016-08-08 (주)세포바이오 중간엽 줄기세포 유래 단백질을 함유하는 면역 반응 억제용 조성물
AU2015367275B2 (en) * 2014-12-19 2021-11-18 Cell Ideas Pty Ltd Improved cell therapies
CN108348555B (zh) * 2015-09-08 2022-07-08 赛尔爱迪尔私人有限公司 细胞扩增方法和治疗组合物
WO2017144552A1 (fr) 2016-02-22 2017-08-31 Centauri Biotech. S.L. Compositions cellulaires pharmaceutiques ou vétérinaires comprenant des cellules stromales mésenchymateuses (csm) et du diméthylsulfoxyde (dmso)
RU2646793C1 (ru) * 2016-12-13 2018-03-07 Акаев Ислам Умарович Средство для собак, обладающее регенеративной активностью

Also Published As

Publication number Publication date
WO2019238952A1 (fr) 2019-12-19
EP3806872A1 (fr) 2021-04-21
AU2019287353A1 (en) 2021-02-04
KR20210021358A (ko) 2021-02-25
US20210236560A1 (en) 2021-08-05
US11413314B2 (en) 2022-08-16
JP2021528489A (ja) 2021-10-21
EP3875097B1 (fr) 2023-06-07
US20210244767A1 (en) 2021-08-12
EP3875097A1 (fr) 2021-09-08
CN112584846A (zh) 2021-03-30
CA3103043A1 (fr) 2019-12-19

Similar Documents

Publication Publication Date Title
MA43709A (fr) Composition pharmaceutique comprenant de l'empagliflozine et ses utilisations
EP3891149A4 (fr) Inhibiteurs de ret, compositions pharmaceutiques et utilisations associées
EP3891148A4 (fr) Inhibiteurs de ret, compositions pharmaceutiques et utilisations associées
EP3500255A4 (fr) Compositions pharmaceutiques ophtalmiques et utilisations associées
EP3838289A4 (fr) Anticorps anti-tigit et ses utilisations
EP3548000A4 (fr) Compositions pharmaceutiques d'atropine
EP3675863A4 (fr) Composition pharmaceutique comprenant de la sépiaptérine et ses utilisations
EP3434285A4 (fr) Composition pharmaceutique et ses utilisations
EP3493799A4 (fr) Composition pharmaceutique decannabis
EP3603620A4 (fr) Composition de liposome et composition pharmaceutique
MA46334A (fr) Composition pharmaceutique liquide
EP3381473A4 (fr) Composition pharmaceutique utilisée pour réduire la graisse localisée et utilisation de la composition pharmaceutique
EP3493798A4 (fr) Composition pharmaceutique decannabis
EP3685828A4 (fr) Composition pharmaceutique ophtalmique, trousse ophtalmique et application pharmaceutique associée
EP3452075A4 (fr) Composition pharmaceutique ophtalmique
EP3412660A4 (fr) Dérivé de sulfonamide et composition pharmaceutique le contenant
EP3858353A4 (fr) Composition pharmaceutique pour prévenir et traiter la nitm et utilisation pharmaceutique associée
EP3573614C0 (fr) Compositions pharmaceutiques pour thérapie combinée
EP3675874A4 (fr) Composition pharmaceutique pour le traitement des chéloïdes et ses utilisations
EP4023227A4 (fr) Composition pharmaceutique et son application
EP3777866A4 (fr) Composition pharmaceutique et application de cette dernière
MA41850A (fr) Nouvelles utilisations pharmaceutiques
EP3402470A4 (fr) Composition pharmaceutique stable
MA43556A (fr) Combinaisons d'un anticorps ox40 et d'un modulateur tlr4 et utilisations de celles-ci
EP3845606A4 (fr) Hydrogel et ses utilisations